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Abstract 
Background: The association between depression after myocardial infarction (post-MI) 
and increased risk of mortality and cardiac morbidity may be due to cardiac disease 
severity. 
Aims: To combine original data from studies on the association between post-MI 
depression and prognosis into one database. To investigate to what extent post-MI 
depression predicts prognosis independently of disease severity. 
Method: Individual patient data meta-analysis of studies, using multilevel, multivariable 
Cox regression analyses.  
Results: Sixteen studies participated, creating a database of 10,175 post-MI patients. HRs 
for post-MI depression were 1.32 (95%CI 1.26-1.38, p<0.001) for all-cause mortality, 
and 1.19 (95%CI 1.14-1.24, p<0.001) for cardiovascular events. HRs adjusted for disease 
severity were attenuated by 28% and 25% respectively. 
Conclusions: The association between post-MI depression and prognosis is attenuated 
after adjustment for cardiac disease severity. Still, depression remains independently 
associated with prognosis, with a 22% increased risk of all-cause mortality and a 13% 
increased risk of cardiovascular events per standard deviation in depression z-score. 
Declaration of interest: None. 
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Introduction 
 
In patients after myocardial infarction (MI), the prevalence of major depression (MDD) 
or elevated depressive symptoms is relatively high at approximately 20% (1), compared 
to around 5% in otherwise healthy people of comparable age (2). Elevated symptoms of 
depression, as measured with symptom questionnaires like the Beck Depression 
Inventory (BDI), are present in around 30% of MI patients (1). Post-MI depression has 
been associated with a worse prognosis, and investigations into the strength of this 
association have been summarized in a number of meta-analyses, which showed 
depressed MI patients are 1.59 to 2.71 times more likely to die early or have new 
cardiovascular events than are non-depressed patients (3-5). Such meta-analyses based on 
summary data, however, have serious limitations. By conducting an individual patient 
data meta-analysis (IPD), a new statistical approach in this field, the main limitations can 
be overcome. 
A major point of discussion in this field is whether depression is an independent 
risk factor for worsened cardiac outcomes, or whether its association with outcome is the 
result of non-causal mechanisms (6). Most importantly, cardiac disease severity may 
confound the association between post-MI depression and prognosis. Depression and 
disease severity, as measured by, for example, LVEF or Killip class, are associated, and 
evidence suggests that patients with more severe cardiac disease have a higher risk of 
depression (7-9). This may be the result of a psychological response to the disease and its 
consequences, as well as of physiological mechanisms involved in cardiac disease 
leading to symptoms of depression, such as elevated inflammation (10) and changes in 
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functioning of the autonomic nervous system (ANS) or the hypothalamic-pituitary-
adrenal (HPA) axis (11, 12). Evidently, patients with more severe disease are also at 
higher risk of adverse cardiac outcomes, such as new cardiac events, rehospitalization 
and cardiac mortality. Similarly, other medical risk factors, such as smoking, and 
diabetes, are likely to be associated with both disease severity and depression (13, 14). 
Therefore more severe disease and exposure to other risk factors could result in both a 
higher prevalence of depression as well as worsened cardiac prognosis, and thereby 
confound the association between depression and CAD outcomes.  
Individual studies find conflicting results when the association between post-MI 
depression and prognosis is adjusted for disease severity, some finding it to be attenuated, 
while others conclude the association remains unchanged. Previous systematic reviews 
and meta-analyses were only able to provide estimates of unadjusted associations, or very 
limited estimates of adjusted associations. This is due to the wide variability of 
adjustments in individual studies, making comparisons across studies impossible. 
Investigating the effects of adjustment is important, however, as variables related to 
cardiac disease severity (15-17) and other health-related variables (13, 14, 18-20) are 
prognostic factors for all-cause mortality (ACM) and cardiovascular events (CVE), and 
are associated with depression. 
The only way to adequately investigate the effects of cardiac disease severity and 
other medical risk factors on the association between post-MI depression and prognosis is 
to combine data from individual studies into a single database First, with one large 
dataset, all combined data will be analyzed with the same techniques, whereas in 
summary data meta-analyses, results are based on different statistical techniques, limiting 
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their comparability. Second, the combined dataset offers the possibility of performing 
new analyses both within and across studies to investigate research questions that have 
not been investigated in the original studies (21). Third, this will allow us to consistently 
adjust for the same variables across studies, providing us with a better estimate of their 
role in the association between post-MI depression and prognosis. Fourth, the combined 
database will contain more raw patient data, which increases statistical power, 
generalizability, and reliability of the results (22-25), providing a more precise estimate 
of the association between post-MI depression and prognosis, and of the effects of the 
individual variables (24). Finally, time-to-event analyses can be performed, to not only 
utilize information on whether or not an event occurred, but also when it occurred (25), 
which is one of the main advantages of IPD meta-analysis (26). The objective of this 
study, therefore, is to conduct an IPD meta-analysis that allows for adjustment for a 
number of important disease severity variables and other health factors that are routinely 
collected in studies of post-MI depression.  
 
Methods 
 
Literature search and selection of studies 
Search strategy 
Studies included in this individual patient data (IPD) meta-analysis were previously 
selected for two regular, summary data (SD) meta-analyses on post-MI depression and 
cardiac prognosis(5, 27). A literature search was performed on January 5th, 2011 to 
identify prognostic studies that investigated the association between post-MI depression 
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and cardiac prognosis since 1975. Depression treatment studies in which baseline 
depression scores and all-cause mortality or cardiovascular events outcomes were 
reported were also eligible. Relevant articles were selected from the electronic databases 
Medline (PubMed), Embase, and PsycINFO without language restrictions. Search terms 
related to depression and myocardial infarction were used and customized to each 
database. Full search strings for each database are listed in Appendix 1. In addition to the 
database searches, major reviews and relevant articles were cross-referenced. Search 
alerts for the three databases mentioned above were activated, to identify relevant studies 
that were published after January 5, 2011. All studies included in the summary data meta-
analyses were eligible for inclusion in the current IPD meta-analysis. 
 
Selection process 
The selection process has been described in detail elsewhere (5, 27). In summary, studies 
were selected by two independent raters according to the following criteria: (1) patients 
had to be hospitalized for MI; (2) depression had to be determined within three months 
after MI using methods originally designed to assess depression (standard self-report 
questionnaires or standardized psychiatric interviews) and validated elsewhere; (3) 
studies had to be prospective and assess cardiovascular prognosis in a depressed patient 
group compared to a non-depressed control group; (4) outcome had to be all-cause 
mortality or cardiovascular events (the latter defined as either non-fatal cardiac events or 
a composite of fatal and non-fatal cardiac events); and (5) the study had to be based on 
original data.  
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Authors of all the studies included in the summary data meta-analysis were 
contacted and invited to participate in the project. Considerable effort was put into 
finding and contacting authors and in obtaining all available databases. When 
corresponding authors could not be contacted at the address specified in the original 
articles, we searched most recent articles and the internet for updated information on the 
authors’ location, and we tried to contact other members of the research groups. Authors 
were asked to share original data they had on post-MI patients regarding demographics, 
depression, disease severity, comorbidities, medication use, and outcomes. Data were 
checked for potential errors, and authors were contacted regarding questions related to the 
design of their study or the datasets they provided. 
 
Depression 
Depression had to be measured using established self-report questionnaires or 
standardized structured diagnostic interviews. For the main analyses, continuous scores 
on the self-report questionnaires were used. Dichotomous scores were used for 
descriptive purposes only, and were based on structured diagnostic interviews where 
available, and on standard cut-off scores (literature-based) on the self-report 
questionnaires where no interviews were available. When multiple depression 
measurement instruments were used, standardized structured diagnostic interviews were 
preferred over self-report questionnaires in constructing dichotomous scores. When 
multiple self-report questionnaires were used in the same study, the one most frequently 
used by the other studies was selected. Across the studies, a number of different self-
report depression questionnaires were used, so total depression scores on these 
 8
questionnaires were standardized to z-scores for analyses. This was done within each 
study.  For some patients, depression questionnaire total scores and dichotomous scores 
were not available due to missing item scores on the questionnaire. When no more than 
25% of the depression items were missing, item scores were imputed with the mean of 
the available items from that patient, to calculate total scores and dichotomized scores. 
 
Disease severity: LVEF, Killip class, and history of MI 
To investigate the role of cardiac factors in the association between post-MI depression 
and prognosis, LVEF, Killip class, and history of MI were used to quantify disease 
severity. These variables were selected because they are known predictors of outcome in 
post-MI patients (18, 19, 28-31), and they were available in a sufficient number of 
patients. They may result in both more symptoms of depression (7) and more adverse 
outcomes (12). 
LVEF was dichotomized into low (<40%) and normal (≥40%), as not all studies 
included continuous values. Killip class was dichotomized into no heart failure (class I) 
and heart failure (classes II, III, and IV), as the 4-category scores were not available in all 
studies. History of MI was dichotomized into “yes” or “no”.  
 
Other risk factors: diabetes, smoking, and BMI 
Several other health-related risk factors were expected to affect the association between 
post-MI depression and prognosis. Of these, diabetes (13, 18, 19, 32), smoking (14), and 
BMI were included in the adjusted analyses, as data on these variables were collected in a 
large number of the patients.  
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Age and sex 
Age and sex were included in the analyses for the minimally adjusted comparison model. 
They may explain part of the association, as they are both related to the risk of depression 
and to physical health prognosis. 
 
Outcome: all-cause mortality and cardiovascular events 
The outcomes of all-cause mortality and new cardiovascular events were considered in 
the analyses. All-cause mortality includes cardiac mortality, and it was included because 
outcome data on all-cause mortality is generally more readily available than specific data 
on (cardiac) causes of mortality or morbidity. Cardiovascular events as defined most 
commonly by the original study authors were accepted, and could be either fatal events, 
non-fatal events, or a combination of both. Cardiovascular events included, for example, 
new MI, unstable angina (UA), and coronary artery bypass graft surgery (CABG). All-
cause mortality and cardiovascular events may overlap when studies included cardiac 
death in both definitions.  
 
Study characteristics 
For each study the following characteristics were summarized: year that the study was 
initiated, percentage of males in the sample, inclusion and exclusion criteria, mean age, 
depression measure, percentage of depressed patients, mean depression scores, duration 
of follow-up, and number of outcome events. 
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Statistical analysis  
The main analyses were performed in Stata 11 (Statacorp LP, TX, USA). All studies 
except one included continuous depression scores, and a number of studies in addition 
contained a binary measure of clinical diagnosis of depression. The one study (33) that 
did not contain continuous depression scores was excluded from the current analyses. 
First, hazard ratios (HRs) were calculated using multilevel Cox proportional hazards 
regression analysis for the studies with time-to-event data. Second, odds ratios (ORs) 
were calculated using logistic regression analysis for all studies, including those with 
dichotomous outcome information only (event versus no event without time-to-event 
data).  
 
Multilevel model 
The individual studies were included as a separate level, resulting in a multilevel model, 
in which the variable “study” was included as a random intercept. Patients across studies 
were likely to differ in systematic ways, for example because of differences in selection 
criteria, study methods, or cardiac care (21). Observations of subjects within studies were 
therefore unlikely to be fully independent. By incorporating a random effect for “study” 
in IPD meta-analysis, we accounted for the fact that outcome rates may vary across 
studies. 
The possibility of a random slope was also investigated, as the strength of the 
association between post-MI depression and prognosis may vary significantly across 
studies. As this did not appear to be the case, random slopes were not included in the final 
models.  
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In the Cox regression analyses, contrast coding of -0.5/0.5 was used for 
dichotomous variables, to insure between-trial variances were equal between groups (e.g. 
male vs. female) (34, 35). 
Potential bias due to standardizing depression scores within each study, with the 
risk of overlooking potential differences in effect due to differences in depression 
severity and prevalence between studies, was investigated by adding a variable to the 
model that describes the level of depression per study (percentage depressed based on 
depression questionnaire scores), as well as an interaction variable of the standardized 
depression scores and the percentage depressed variable. As the analysis showed that this 
bias was virtually non-existent, we did not include these variables in the final models. 
 
Bootstrapping 
A bootstrapping procedure with 1000 replications was used for the analyses, to increase 
the robustness of the confidence intervals (36), and to account for the fact that some of 
the depression z-scores were not distributed normally. 
 
Model construction 
The models were built as follows: First, a base model to which subsequent adjusted 
models could be compared was created by including age, sex, and the depression z-scores 
as predictors of prognosis. As our primary interest was in the influence of individual 
variables on the association between post-MI depression and prognosis, we then added 
each preselected variable separately to this base model in minimally adjusted analyses. 
Not all studies had data on each of these variables, and to be able to compare differences 
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between the base and adjusted models, patients who did not have data on the relevant 
variable were excluded from the relevant analyses in both models. Cardiac disease 
severity was represented by history of MI, Killip class, and LVEF. Diabetes, smoking and 
BMI were added as risk factors for poor prognosis. A variable was considered to explain 
a substantial portion of the variance if it changed the effect size (log HR) by 5% or more 
(37). Variables that were also significant predictors (p≤0.05) of outcome were considered 
to substantially add to the variance. As not all studies had time-to-event data, additional 
logistic regression analyses were performed and these models were built in the same way 
as for Cox regression analyses. 
Second, we investigated the extent to which the association between post-MI 
depression and prognosis was attenuated by adjusting for all of the risk factors. As not all 
studies had data on all variables, these multivariable analyses could only be performed 
with data from a limited number of studies. Nevertheless, this provides the best estimate 
of the extent to which post-MI depression independently predicts cardiac outcomes. 
 
Model assumptions 
The proportional hazards assumption for Cox regression was tested, as well as the 
assumption of linearity in the association between post-MI depression and prognosis. The 
model assumptions were met in most cases. In the few cases that they were not, the 
effects of violation of the assumption were further investigated and determined to be 
minimal. Analyses were therefore run for these models in the same way as the other 
models, for the sake of clarity and interpretability of the results. 
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Patient characteristics 
Patient characteristics were presented separately for depressed and non-depressed 
patients. Differences in these characteristics between depressed and non-depressed 
patients were assessed with independent samples t-tests for normally distributed 
continuous variables, and Mann-Whitney U-tests for non-normally distributed continuous 
variables. Dichotomous and categorical variables were compared using Pearson’s Chi-
square test. 
 
Effects of non-participation of eligible studies 
To investigate whether there were any systematic differences (acquisition bias) between 
participating and non-participating studies that may affect the results of the meta-analysis 
(38), we compared results of included and excluded studies concerning strength of the 
association and study characteristics. 
Results 
Study participation 
A total of 6,145 articles were identified through the literature search, cross-referencing, 
and personal communication. Of those, 28 studies were ultimately included in the meta-
analysis. Two additional studies were identified through search alerts (39) and personal 
communication (40), resulting in a total number of 30 eligible studies. The authors of 16 
studies provided data for the IPD meta-analysis, resulting in a combined database of 
10,175 patients1. Figure 1 is a flow-chart of the literature search and data acquisition. 
                                                 
1
 The data of one study were not used for the current analyses, as there were no continuous depression 
scores (Rafanelli). However, these data will be available for future substudies. 
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Fourteen studies were not included, seven because authors could not be contacted, five 
because data were not available, and two because the authors were not interested in 
participating. An overview of participating studies is given in Table 1. Complete reports 
of study design and methodology of the individual studies are published elsewhere (20, 
31, 39-56). Appendix 2 is an overview of non-participating studies. 
 
Study characteristics 
The 16 participating studies originated from 9 different countries. The mean sample size 
was 615 patients per study (SD 711), ranging from 61 to 2,889 patients. Studies 
originated from 1985 to 2006. Mean age per study ranged from 56-65 years (m=61), and 
the mean percentage of males ranged from 33%-85% (m=72%). All studies included MI 
patients based on standardized diagnostic criteria. Most of the exclusion criteria 
concerned life-threatening illnesses or psychiatric disorders other than depression, MI due 
to a surgical procedure (e.g. CABG, valve replacement, etc.), or cognitive or 
communication difficulties.  
 Depression was measured with a self-report depression questionnaire, a structured 
clinical interview, or both. The self-report depression scales that were used included the 
BDI-1A, BDI-II, BDI-Fast Screen (FS), the depression subscale of the Hospital Anxiety 
and Depression Rating Scale (HADS-D), and Zung Self-rating Depression Scale (SDS). 
Structured clinical interviews included the Depression Interview and Structured Hamilton 
(DISH), the Composite International Diagnostic Interview (CIDI), and the Structured 
Clinical Interview for DSM Disorders (SCID). The percentage of depressed patients was 
lower when based on diagnostic interviews (11%-15%) than when based on elevated 
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symptoms on self-report questionnaires (17%-69%). Follow-up time ranged from 350 to 
2,428 days (1 – 6.7 years), with a mean of 1,151 days (3.2 years). 
 
Patient characteristics 
Individual patient data were combined for 10,175 MI patients. 4,043 patients (40%) had a 
major depression, or elevated symptoms of depression and 6,132 patients (60%) were not 
depressed 2. Nineteen percent of patients had a history of one or more MIs prior to the 
index MI, 23% had low LVEF, and 18% had a Killip class higher than I. Twenty-one 
percent of those measured had comorbid diabetes, 45% were (ever) smokers, and the 
mean BMI was 27 (Table 2). 
 
Adjusted association between post-MI depression and prognosis: Cox regression 
analyses 
Base model (adjusted for age and sex) 
Figure 2 shows survival curves for the two outcomes all-cause mortality and 
cardiovascular events, with separate lines for depressed and non-depressed patients, and 
adjusted for age and sex. 
Rates of all-cause mortality were stable over time, and were consistently higher 
for depressed patients than for non-depressed patients. The rate of cardiovascular events 
was highest soon after the MI, and became relatively stable after about 1 year. The rate of 
cardiovascular events was higher for depressed than for non-depressed patients. 
                                                 
2
 Note that some studies may have oversampled depressed patients, so these numbers may overrepresent 
depression percentages in MI patients. 
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The base Cox regression model for all-cause mortality (adjusted for age and sex) 
produced an HR for depression (z-scores) of 1.32 per SD (95%CI 1.26-1.38, p<0.001). 
Adjustment for age and sex increased the strength of the association between post-MI 
depression and all-cause mortality by 17% (see Table 3).  
In the cardiovascular events model the HR (adjusted for age and sex) for 
depression (z-scores) was 1.19 per SD (95% CI 1.14-1.24, p<0.001). Adjustment for age 
and sex did not substantially alter the strength of the association between post-MI 
depression and cardiovascular events (Table 4). 
 
Univariate models 
All three cardiac disease severity variables explained a substantial portion of the 
association between post-MI depression and all-cause mortality, with the dichotomized 
variables for Killip class and LVEF explaining 19% and 15%, respectively, and history of 
MI explaining 8%. Of the general health variables diabetes, smoking, and BMI, only 
diabetes explained a considerable part (7%) of the association between post-MI 
depression and all-cause mortality. Table 3 is a summary of the results of unadjusted and 
adjusted analyses. 
For cardiovascular events, all three variables relating to cardiac disease severity 
explained a substantial portion of the association with post-MI depression, with the 
dichotomized variables for Killip class and LVEF explaining 12% and 10%, respectively, 
and history of MI explaining 9%. Of the general health variables diabetes, smoking, and 
BMI, again only diabetes explained a considerable part (7%) of the association (Table 4). 
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Multivariable models 
The following results are based upon the three studies that included all variables (i.e., 
history of MI, Killip class, LVEF, diabetes, smoking, and BMI). When combining all 
general health and disease severity related variables in one model, the adjusted HR for 
all-cause mortality was 1.23, compared to 1.33 unadjusted, an attenuation of 28%. All 
variables except sex and BMI independently explained part of the association between 
post-MI depression and prognosis. Figure 3 (top panel) is a survival curve of the model 
adjusted for age, sex, history of MI, LVEF, Killip class, diabetes, BMI, and smoking. 
Note that this figure is based on the three studies only that contained all these variables. 
 Adjusting for the three cardiac disease-related variables only, the HR for all-cause 
mortality was 1.22 compared to 1.32 unadjusted, an attenuation of 29%. This means that 
the cardiac disease-related variables are responsible for nearly all of the attenuation in the 
full model. Model fit improved when age, sex, history of MI, LVEF, Killip class, and 
diabetes were subsequently added. Model fit did not improve after further adjustment for 
BMI and smoking. 
For cardiovascular events, when combining all general health and disease 
severity-related variables in one model, the adjusted HR was 1.12, compared to 1.17 
unadjusted, an attenuation of 25%. All variables except BMI independently explained 
part of the association between post-MI depression and prognosis. Figure 3 (bottom 
panel) is a survival curve of the model adjusted for age, sex, history of MI, LVEF, Killip 
class, diabetes, BMI, and smoking. Note that this figure is based on the two studies only 
that contained all these variables. 
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 Adjusting for the three cardiac disease-related variables only, the HR for 
cardiovascular events was 1.13 compared to 1.17 unadjusted, an attenuation of 21%. This 
means that the cardiac disease-related variables were responsible for most of the 
attenuation in the full model. Congruent with the all-cause mortality analyses, model fit 
improved when subsequently adjusting for age, sex, history of MI, LVEF, Killip class, 
and diabetes. Model fit did not improve after further adjustment for BMI and smoking. 
 
Adjusted association between post-MI depression and prognosis: logistic regression 
analyses  
Five studies (2,468 patients) did not have time-to-event data, and therefore logistic 
regression analyses were performed in addition to the Cox regression analyses. Of the 
8,366 patients who had depression z-scores as well as outcome data on all-cause 
mortality, 1,136 patients (14%) died. Of 3,206 depressed patients, 636 (12%) died, and of 
3,206 non-depressed patients, 500 (16%) died. Of the 8,878 patients who had depression 
z-scores as well as outcome data on cardiovascular events, 3,067 experienced a fatal or 
non-fatal cardiac event (35%). Of 3,747 depressed patients, 1,449 (39%) experienced a 
fatal or non-fatal cardiac event, and of 5,135 non-depressed patients, 1,168 (32%) 
experienced an event. Base model (adjusted for age and sex). 
The base logistic regression model for all-cause mortality (adjusted for age and 
sex) produced an OR for depression (z-scores) of 1.41 per SD (95%CI=1.34-1.49, 
p<0.001) (Table 5). Adjustment for age and sex increased the strength of the association 
between post -MI depression and all-cause mortality by 18%. 
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 The OR for depression in the cardiovascular events model (adjusted for age and 
sex) for depression (z-scores) was 1.25 per SD (95%CI=1.19-1.32, p<0.001) (Table 6). 
Adjustment for age and sex did not substantially alter the strength of the association 
between post-MI depression and cardiovascular events. 
 
Univariate logistic models 
For the all-cause mortality and cardiovascular events analyses, the variables diabetes, 
history of MI, LVEF and Killip class each explained a substantial part (≥more than 5%) 
of the association between post-MI depression and all-cause mortality and improved 
model fit. The variables smoking and BMI did not add to the model (Tables 5 and 6).  
  
Multivariable logistic model 
When all variables were added to the model at once, 3 studies and 2,225 patients 
remained, and the adjusted OR for depression was 1.24 per SD (95% CI=1.07-1.44, 
p<0.001) in the all-cause mortality model. The added variables explained 30% of the 
association between post-MI depression and all-cause mortality. When including the 
variables relating to cardiac disease severity only (i.e., history of MI, LVEF, Killip class), 
the OR was 1.27 per SD (95% CI = 1.17-1.37, p<0.001). These variables explained 25% 
of the association (Table 5). 
 The complete model for cardiovascular events included 2 studies and 1964 
patients, and resulted in an OR for depression of 1.18 per SD (95%CI=1.00-1.39, 
p=0.053). The variables explained 23% of the association between post-MI depression 
and cardiovascular events. The association was no longer significant after adjusting for 
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all variables. When including the variables relating to cardiac disease severity only 
(history of MI, LVEF, Killip class), the OR was 1.19 per SD (95%CI = 1.12-1.26, 
p<0.001). These variables explained 19% of the association (Table 6). 
 
Participation 
Of the 30 studies that were included in the summary data meta-analyses, the authors of 14 
studies participated and contributed their data. In addition, 2 studies that were published 
after the summary data meta-analysis contributed their data. Combining all available 
studies resulted in inclusion of 51% (10,175 of 19,859) of eligible patients. 
To estimate the impact of non-participation of studies on the association, 2-year 
ORs for post- MI depression were compared for included and excluded studies, as 2-year 
follow-up data were available for most studies. For comparison purposes, this was done 
on the studies that were included in the original summary data meta-analysis. For 
excluded studies that reported on all-cause mortality, the unadjusted OR was 1.98 
(95%CI 1.62-2.42, p<0.001) and for included studies, the unadjusted OR was 2.45 
(95%CI 1.46-4.14, p<0.001), with no significant difference. However, for cardiovascular 
events, the ORs of excluded and included studies differed significantly (p=0.04), with an 
unadjusted OR of 1.83 (95%CI 1.40-2.39, p<0.001) for excluded studies and 1.34 
(95%CI 1.17-1.54, p<0.001) for included studies.
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Discussion 
 
Main results 
The association between post-MI depression and all-cause mortality and cardiovascular 
events was partly attenuated, but remained significant, after adjustment for cardiac 
disease severity and other health variables. In Cox regression analyses, adjusting for 
cardiac disease severity, i.e. history of MI, LVEF and Killip class, resulted in an 
attenuation of 29% in the all-cause mortality model and 21% in the cardiovascular events 
model. Adjustment for the health-related variables smoking and BMI did not result in an 
attenuation of the association between post-MI depression and all-cause mortality or 
cardiovascular events, but adjustment for diabetes attenuated the association for both 
outcomes by 7%. In logistic regression analyses, results were similar, 
The fact that, after attenuation for variables indicating cardiac disease severity, the 
association between post-MI depression and prognosis remains can mean several things. 
First, adjustments for more variables indicating disease severity may result in stronger 
attenuation. Second, other mechanisms than disease severity are likely to be involved, 
which may be either mediators in the association between depression and cardiac disease 
occurring after depression onset, or causal factors preceding both depression and cardiac 
disease. For example, depression has been associated with changes in ANS functioning, 
and in HPA-axis activity (11, 57, 58), increased inflammation (11, 59) and platelet 
reactivity (11, 60, 61)These physiological processes may be particularly disturbed in 
depressed MI patients and they are all involved in the development and progression of 
cardiovascular disease. They may therefore be mediating mechanisms through which 
 22
depression in MI patients can affect prognosis. They may, however, also be involved in 
both the onset of depression and of cardiac disease progression, in which case they are 
confounders of the association between post-MI depression and prognosis. 
In addition to physiological mechanisms, behavioral mechanisms may be involved as 
mediators. Depression in MI patients has been associated with a range of behaviors that 
are unhealthy and may increase the risk of mortality and new cardiac events. Depressed 
patients have poor medication adherence (62-64), and low adherence to rehabilitation 
programs (65). Moreover, they display more generally unhealthy behaviors, such as 
maintaining a high-fat diet, smoking, and a lack of physical exercise (66-68).  
These unhealthy behaviors may be the result of psychological mechanisms associated 
with depression. For example, low self-efficacy in depressed cardiac patients may imply 
they are less likely to believe they can control and influence their prognosis, for example 
by changing unhealthy behavior patterns. In a sample of heart failure patients, low self-
efficacy was associated with poor adherence (69), and in another study, low self-efficacy 
predicted poor self-management behaviors in MI patients (70). Interestingly, self-efficacy 
appears to be associated with poor adherence and health status independently of 
depression (69-71). However, evidence also suggests that the association between self-
efficacy and worsened prognosis is caused by worse cardiac disease severity in patients 
with low self-efficacy (72), which is consistent with the confounding role of disease 
severity in the association between depression and prognosis. 
The attenuation after adjusting for LVEF and Killip class was somewhat stronger for 
all-cause mortality than for cardiovascular events in both time-to-event (LVEF 15 vs. 
10%, Killip class 19 vs. 12%) and logistic (LVEF 12 vs. 8%, Killip class 13 vs. 7%) 
 23
regression analyses. This is unexpected, as these variables appear to be more strongly 
related to cardiac disease than to all-cause mortality and would therefore be expected to 
explain more of the association between depression and cardiac outcomes than of the 
association between depression and all-cause mortality. Potentially, however, poor Killip 
class and low LVEF, symptoms of heart failure, are markers of poor health in general. 
Heart failure is often comorbid with other serious health problems, such as lung disease, 
obesity and diabetes, with 40% of heart failure patients having more than 5 comorbid 
conditions (73). Any of these health problems may escalate and cause mortality, not just 
cardiac disease (73). This may explain why adjusting for LVEF and Killip class 
attenuates the association between depression and all-cause mortality more than it does 
the association between depression and cardiovascular events, as patients with low LVEF 
or Killip class have a higher risk of dying early of any cause, not just cardiac causes, than 
do patients with normal LVEF or Killip class. 
 
Results in the context of previous studies 
The attenuation of the association between post-MI depression and cardiac prognosis 
after adjustment is a consistent finding in studies in this field (4, 15-17), but identifying 
the factors that cause this attenuation has proven to be difficult thus far. In the summary 
data meta-analysis preceding this IPD meta-analysis (5), reported analyses adjusting for a 
number of factors, including disease severity-related variables, attenuated the association 
between post-MI depression and prognosis by on average 21%. However, adjusted 
analyses were reported in a limited number of studies only, using different sets of 
variables, and adjustment was done for several variables at once, making it impossible to 
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see to what extent individual variables were responsible for attenuation. The fully 
adjusted model in this IPD meta-analysis resulted in slightly higher attenuation than the 
summary data meta-analysis. Similar, but greater, attenuation was found in another 
summary data meta-analysis by Nicholson et al.(4). They reported that a pooled OR of 
adverse outcomes in depressed versus non-depressed MI patients, adjusted for diverse 
variables, was attenuated by 41%. So overall, it appears that in this study we have 
identified the disease specific variables that are responsible for the largest portion of the 
attenuation known so far. 
The summary data meta-analysis preceding this IPD meta-analysis resulted in 
ORs of 2.25 for all-cause mortality, 2.71 for cardiac mortality, and 1.59 for 
cardiovascular events. Similar effect sizes were reported in other meta-analyses (3, 4). 
The current IPD meta-analysis resulted in HRs of 1.32 for all-cause mortality and 1.19 
for cardiovascular events. This apparent difference in the effect size is mainly due to the 
fact that these ORs and HRs are based on different analyses. The associations in the 
previous meta-analysis were based on (maximally) two-year follow-up data, 
dichotomized depression scores, and logistic regression analysis. The main associations 
in the current IPD meta-analysis are based on longer follow-up data, continuous 
depression scores, and Cox regression analyses. In previous meta-analyses, dichotomous 
depression scores were used, so the effect sizes represented the increase in risk associated 
with the difference between depressed and non-depressed patients, which is a large 
difference. Using continuous depression scores, the HR in this IPD meta-analysis 
represent the increase in risk associated with one SD increase in continuous depression 
scores, so the steps involved are smaller, and results are more precise. All these 
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differences, and the fact that the risk of spurious results due to low numbers of events is 
small in the IPD meta-analysis, explain these apparently different results in the IPD meta-
analysis compared to the summary data meta-analysis. As depression is by nature a 
continuous variable instead of a dichotomous variable, expressing the effect on prognosis 
per SD is more accurate than expressing it dichotomously. 
 
Strengths and limitations 
Individual studies often lack power to adjust for several variables, and summary data 
meta-analyses are limited to combining reported data. Instead, combining individual 
patient data provides more statistical power, consistent analysis of data across studies, 
and the possibility for additional analyses not performed in the original studies. Most 
important for the current study is that IPD meta-analysis allowed us to investigate in 
detail some of the variables responsible for the attenuation of the association between 
post-MI depression and prognosis. In addition, time-to-event analyses could be 
performed. As time-to-event analyses combine the occurrence and timing of events (25), 
they are more reliable and stable than, for example, ORs, which are often used in 
summary data meta-analyses. This resulted in a relatively accurate estimate of the effect 
of cardiac disease severity on the association between post-MI depression and prognosis.  
There were also a number of limitations to this study: First, the analyses were to 
some extent limited in power, as, in addition to not all studies participating, some of the 
participating studies did not contain all variables that were selected for analyses. For 
example, for analyses with Killip class and LVEF, a limited number of studies (6 and 5) 
were available. However, these analyses are still based on a large number of patients, and 
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there is no other way to perform such analyses. Therefore they do have an added value in 
summarizing the role of these variables in the association between post-MI depression 
and prognosis.  
With regard to participation, of 30 eligible studies, 16 were included, of which the 
majority were from Western, first world countries. Although low, this level of 
participation is common for IPD meta-analyses of observational studies (21). For 
example, Schmid et al. achieved participation of 11 of 14 of the researchers of clinical 
trials (74), but Sternberg et al. achieved participation of 13 of 24 (54%) observational 
studies (75), and Wicherts et al. of 64 of 249 studies (26%) (76). For cardiovascular 
events, the ORs in eligible non-included studies were higher than those in included 
studies (1.83 vs. 1.34). This suggests that, for this outcome, the IPD meta-analysis 
potentially underestimates the strength of the association. However, the higher, more 
extreme ORs in the non-included studies came from the smaller studies. These, if 
included, would have had a relatively smaller effect on the overall combined OR than the 
larger included and non-included studies, of which the ORs were more moderate. In 
addition, there were no other appreciable differences between eligible studies that were 
included and those that were excluded. We therefore concluded that the data available for 
this IPD meta-analysis, and the results of the analyses, are fairly representative of MI 
patients in first world countries, and that the benefits of analyzing IPD outweighed the 
potential effects of excluding relevant studies. 
Two of the studies included were trials of depression treatment (ENRICHD, 
MIND-IT). As these studies collected information on both depression and outcomes, they 
were considered relevant for answering our research question. These data may differ from 
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that of observational studies, as patients were treated for depression, which may affect 
depression as well as all-cause mortality and cardiovascular outcomes. However, the 
depression scores that were included in the analyses for this study were obtained before 
treatment started and were therefore not affected by the interventions. In addition, the 
interventions were at best moderately effective in reducing depression and did not have 
an effect on all-cause mortality and cardiovascular outcomes (77-79). 
Second, an inherent problem of IPD meta-analyses is that individual studies use 
different methods to assess relevant variables. In the current IPD meta-analysis, variables 
were harmonized across studies, with the main issue being depression measurement. 
However, such harmonization always contains the risk of combining measurements based 
on different underlying constructs (80). For depression, however, most studies used the 
BDI, making their data comparable. The other questionnaires used were the BDI-FS, 
HADS-D, and Zung SDS, which are highly correlated with the BDI. Item Response 
Theory methods of harmonization could not be used here, as they require individual 
depression item scores, which were not available for 4 of the 16 studies. Standardizing 
depression scores within each study may introduce bias by leveling out any differences in 
depression severity and prevalence between studies, which may affect the strength of the 
association between post-MI depression and prognosis. If the strength of the association 
is different for patients with less severe vs. more severe depression, this would not be 
accounted for by these standardization method. We therefore investigated whether this 
bias was present in our study by adding a variable to the model that describes the level of 
depression per study (percentage depressed based on depression questionnaire scores), as 
well as an interaction variable of the standardized depression scores and the percentage 
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depressed variable. If this interaction variable would be a significant predictor in the 
model, this would mean that the association between depression and prognosis is 
moderated by level of depression. This, however, was not the case (HR 1.00, 95% CI 
0.99-1.01, p = 0.915). We are therefore confident that this potential bias did not affect our 
results. 
Third, although LVEF, history of MI, and Killip class are important predictors of 
post-MI mortality and morbidity, they are not the only risk factors associated with 
worsened prognosis. Other important variables that are related to disease severity, for 
example, heart rate, blood pressure, treatment with PTCA or CABG, etc. (81), could not 
be included in the analyses. Similarly, a number of non-cardiac comorbidities, such as 
chronic obstructive pulmonary disease (COPD) and kidney disease are known to be 
associated with worsened outcomes (82). Also, the type of treatment in the acute phase 
and subsequent pharmacological treatment can affect outcomes. Finally, behavioral 
variables that were not incorporated in the model can attenuate the association. In a 
sample of stable CAD patients, Whooley et al. found that physical activity is an important 
confounder of the association (37). Adding these variables to a prediction model is likely 
to result in additional attenuation of the association between post-MI depression and 
prognosis. However, related research suggests the association may still remain. Kronish 
et al., for example, found that depression after acute coronary syndrome (ACS) remained 
associated with all-cause mortality, even after adjusting for GRACE risk score and LVEF 
(83) and Meurs et al. found similar results after adjusting the association for GRACE risk 
score in MI patients (84). 
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Finally, the outcome of all-cause mortality is somewhat imprecise in investigating 
the association between post-MI depression and prognosis. First, in some studies, cardiac 
deaths may be included in the outcome “cardiovascular events” as well as in the outcome 
“all-cause mortality”.  Therefore, the results of the analyses for the two outcome 
measures are based in part on the same event data. Second, as all-cause mortality includes 
non-cardiac cases of mortality, the results of this study might encompass a part of the 
association between post-MI depression and prognosis that is not specific to cardiac 
disease. However, the reason to use all-cause mortality was that the outcome data 
available in studies of post-MI depression often include mortality without specified 
causes of death. This was preferred over excluding studies without cardiac-specific 
outcome measures, as it would considerably reduce the number of available studies and 
otherwise relevant data. In addition, all-cause mortality includes cardiac mortality, and 
data on cardiac mortality and morbidity were analyzed separately to obtain results that 
were maximally specific. As all-cause mortality includes non-cardiac mortality, the 
proportion of variance in the association between post-MI depression and all-cause 
mortality explained by cardiac disease severity may be smaller than it would be when 
only cardiac mortality were included. This is because part of the association between 
post-MI depression and all-cause mortality is non-specific for cardiac disease and may 
therefore not be affected by adjusting for cardiac disease related variables. 
 
Conclusions 
This study represents an important step forward in understanding the association between 
post-MI depression and prognosis, as it is the first time that the amount of attenuation of 
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this association by cardiac disease severity has been systematically quantified. Therefore, 
an important part of the inconsistencies in previous literature, due to conflicting results 
and methodological issues, has been solved. It appears more severe cardiac disease is a 
common underlying factor resulting in both poorer prognosis and higher risk of 
depression. In addition, however, post-MI depression remains independently associated 
with poorer cardiac prognosis, despite this attenuation. This means either that it is 
depression itself that adversely affects outcomes, or that unknown mechanisms can 
further explain the association. 
Future research should focus not only on the mechanisms through which post-MI 
depression is associated with poorer cardiac outcomes, but also on better ways to treat 
post-MI depression. As depression is widely recognized to be an extremely 
heterogeneous concept, with many different etiologies, symptoms profiles, and clinical 
courses, there currently is a movement towards more individualized treatments. Within 
such individualized depression care for MI patients, integrating depression treatment and 
treatment of major indicators of cardiac disease severity could help improve prognosis, 
which post-MI depression treatments as of yet have not achieved. 
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Figure 1: study selection and data acquisition 
5837 excluded 
no original data; no MI at baseline; no 
depression, or no non-depressed 
control group; outcome not ACM or 
CVE; depression not assessed within 
3 months after MI 
6145 citations identified 
308 citations retrieved 
278 excluded 
duplicate data; no original data; no 
MI at baseline; no depression, or no 
non-depressed control group; 
depression not assessed within 3 
months after MI; no validated 
depression measurement instrument 
30 studies contacted 
 14 excluded 
7 no response; 5 data not available; 2 
not interested 
16 studies included in 
analysis 
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Table 1: Overview of participating studies 
PI, study name, 
country 
Start 
of 
study 
N3 / % 
male 
Inclusion criteria Exclusion criteria Mean 
age 
Depression 
measurement 
instrument1 
and cut-off 
score 
N / % 
depressed 
Mean 
depression 
score (SD) 
Mean 
follow-
up time 
(days) 
No. of 
events 
ACM / 
CVE 
R. Carney, J. A. 
Blumenthal 
ENRICHD and  
ancillary HRV 
study2 
USA(41-43) 
1996 / 
1997 
2848 / 
58% 
standardized criteria for 
MI; 
low social support or 
depression 
ancillary study: no 
depression or social 
isolation, otherwise 
eligible for ENRICHD 
other life-threat. 
med. illn.; cogn. 
impairm.;  too ill; 
other major psych. 
disord.; 
unable/refused to 
participate 
61 BDI-1A ≥ 10 1951 / 69% 14.13 (8.87) ACM: 
834 
CVE: 
609 
ACM: 
350 
CVE: 
1151 
J. Ormel, P. de 
Jonge, 
MIND-IT 
The 
Netherlands(40) 
1999 1814/77% standardized criteria for 
MI 
age ≥ 18 
other life-threat. 
med. illn.; MI 
during hosp. for 
other reason;  
psych. depr. 
treatm; part. in 
conflicting clin. 
trial  
61 BDI 1-A ≥ 10 BDI: 474 / 
26% 
6.77 (6.18) ACM: 
2167 
CVE: 
1517 
ACM: 
278 
CVE: 
784 
J. Ormel, P. de 
Jonge 
DepreMI 
The 
Netherlands(44) 
1997 528 / 81% standardized criteria for 
MI 
other life-threat. 
med. illn.; cogn. 
impairm.; too ill; 
unable to 
communicate; MI 
during hosp. for 
other reason 
61 modified Dutch 
version of CIDI 
2.1  
 
BDI 1A ≥ 10 
CIDI: 73 / 
15% 
 
BDI: 117 / 
23% 
6.80 (6.12) ACM: 
2663 
CVE: 
1851 
ACM: 
116 
CVE: 
237 
J. Denollet 
 
The 
Netherlands(20) 
2003 501 / 78% Standardized criteria for 
MI;  
Age > 30  
other life-threat. 
med. illn.; cogn. 
Impairm.  
60 BDI-1A ≥ 10 132 / 26% 7.03 (6.18) ACM: 
1374 
CVE: 
1284 
ACM: 
38 
CVE: 82 
F. Doyle, H. M. 
McGee 
 
Ireland(55) 
2003 433 / 75% standardized criteria for 
ACS (only MI patients 
were included in the IPD 
meta-analysis) 
nr 63 HADS-D > 7 
BDI-FS > 3 
HADS-D 
or BDI-FS: 
75 / 17% 
HADS-D: 
4,14 (3,26) 
BDI-FS: 1.88 
(2.69) 
ACM: 
356 
CVE: na 
ACM: 
17 
CVE: na 
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F. Doyle, H.M. 
McGee 
  
Ireland(56) 
2006 285 / 80% standardized criteria for 
ACS (only MI patients 
were included in the IPD 
meta-analysis) 
patient too 
distressed 
61 HADS-D > 7 
BDI-FS (6-item) 
> 3 
either 
HADS-D 
or BDI-FS: 
78 / 27%  
HADS-D: 
33 / 12%; 
BDI-FS 69 
/ 24% 
HADS-D: 
3,52 (3,07) 
BDI-FS: 2.15 
(2.84) 
ACM: 
427 
CVE: 
427 
ACM: 
19 
CVE: 67 
S. Bergerone 
 
Italy(45) 
1999 98 / 78% standardized criteria for 
MI 
in-hosp. mort.; 
other major psych. 
disord.; 
alcoholism; 
antidepr. therapy 
62 struct. int. based 
on DSM-IV 
criteria 
BDI 1A ≥ 10 
MDD: 14 / 
14% 
BDI: 35 / 
34% 
BDI: 8.34 
(8.48) 
ACM: 
1485 
CVE: 
1485 
ACM: 6 
CVE: 29 
S.H. Hosseini 
 
Iran(39) 
2004 540 / 69% standardized criteria for 
MI 
other life-threat. 
med. illn.; MI 
result of CABG or 
angiogr.; too ill 
58 BDI 1A ≥ 10 355 / 66% 14.20 (9.80) na (24 
months) 
ACM: 
naCVE: 
55 
D.A. Lane 
 
UK(46, 47) 
1997 288 / 75% standardized criteria for 
MI 
other life-threat. 
med. illn.; cogn. 
impairm.; MI 
result of CABG or 
angiogr.; unable to 
communicate; too 
ill 
63 BDI 1A ≥ 10 89 / 31% 7.72 (6.26) ACM: 
976 
CVE:na 
ACM: 
38 
CVE: na 
L. Pilote 
 
Canada(48) 
1996 553 / 81% acute MI; surv. up to 24 
hours after hosp. adm.; 
adm. through emergency 
dept. 
phys. unable to 
respond to quest.; 
unable to 
communicate 
60 BDI 1  ≥10 193 / 35% 9.07 (7.93) ACM: 
350 
CVE: 
205 
ACM: 
32 
CVE: 
222 
K. Parakh, R.C. 
Ziegelstein 
 
USA(49) 
1995 284 / 57% standardized criteria for 
MI 
other life-threat. 
med. illn.; cogn. 
impairm.; too ill 
65 SCID 
 
BDI 1A ≥10 
MDD: 29 / 
10% 
BDI: 56 / 
20% 
BDI: 5.76 
(6.15) 
ACM: 
2428 
CVE: na 
ACM: 
153 
CVE: na 
C. Rafanelli 
 
Italy(33) 
1995 61 / 85% standardized criteria for 
MI; first MI 
nr 59 modified SCID 
(minor and 
major 
depression 
7 / 11% na na (24 
months) 
ACM: 4 
CVE: 22 
H. Sato 
OACIS 
Japan(51) 
1998 1042 / 
80% 
standardized criteria for 
MI 
in-hosp. mort.; 
other major psych. 
disord.;  unable to 
communicate 
63 ZSDS ≥ 40 438 / 42% 38.03 (9.07) na (12 
months) 
ACM: 
na 
CVE: 
283 
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R.P. Steeds 
 
UK(52) 
1999 131 / 33% MI; age < 75 nr 60 BDI-II ≥ 14 52 / 40% 12.42 (9.09) ACM: 
457 
CVE: na 
ACM: 
11 
CVE: na 
S.L. Grace 
 
Canada(53) 
1997 468 / 72% confirmed MI; age ≥ 18 too ill; unable to 
communicate 
61 BDI 1A  ≥ 10 136 / 28% 7.93 (7.22) na (12 
months) 
ACM: 
29 
CVE: 
101 
C. Welin 
 
Sweden(54) 
1985 270 / 84% standardized criteria for 
MI; first MI; age < 65 
nr 56 ZSDS ≥ 40 96/ 36% 36.76 (8.58) na (120 
months) 
ACM: 
65 
CVE: 73 
1
 Depression measurement instrument used in the current individual patient data meta-analysis.  
2
 Part of the non-depressed control group came from an ancillary study and part of the patients in the non-depressed control group had low social support. Depressed patients were 
oversampled for the purpose of the study. 
3 Number of patients included in IPD-meta-analysis. 
Abbreviations: ACM: All-cause mortality; ACS: acute coronary syndrome; BDI: Beck Depression Inventory; BDI-FS: Beck Depression Inventory Fast Scale; CIDI: Composite 
International Diagnostic Interview; CVE: cardiovascular events; DepreMI: Depression after Myocardial Infarction; ENRICHD: Enhancing Recovery in Coronary Heart Disease; 
HADS-D: Hospital Anxiety and Depression Scale-Depression subscale; HRV: heart rate variability; MDD: major depression disorder; MI: myocardial infarction; MIND-IT: 
Myocardial Infarction and Depression Intervention Trial; na: not available; nr: not reported; OACIS: Osaka Acute Coronary Insufficiency Study; PI: primary investigator; SCID: 
Structured Clinical Interview for DSM; SD: standard deviation; ZSDS: Zung Self-rating Depression Scale 
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Table 2: Baseline patient characteristics by depression status 
 Depressed 
patients (n=4,043) 
Non-depressed 
patients (n=6,132) 
p-value 
difference 
N measured 
Demographic 
characteristics 
    
Age 60.5 (12.2) 61.4 (11.6) <0.001 10,171 
Sex (% male) 63.3 75.7 <0.001 10,175 
Employment status (% 
employed) 
43.1 46.6 0.004 6,528 
Partner status (% with 
partner) 
63.7 73.7 <0.001 6,412 
Cardiac disease 
severity 
    
History of MI (% yes) 21.8 17.0 <0.001 9,646 
LVEF (% of patients <40%) 27.0 21.3 0.001 3,505 
Killip class (% poor) 21.6 15.7 <0.001 7,532 
PTCA (%) 48.7 43.6 <0.001 7,679 
History of PTCA (%) 13.4 9.3 <0.001 4,830 
CABG (%) 11.5 8.5 <0.001 8,139 
History of CABG (%) 11.4 8.2 <0.001 4,849 
Thrombolysis (%) 32.5 34.8 0.037 8,065 
Congestive HF (%) 29.0 12.3 <0.001 6,104 
Other risk factors     
Diabetes (%) 27.8 17.3 <0.001 10,060 
Smoking (%) 43.1 45.6 0.017 9,942 
BMI (mean, (SD)) 27.6 (5.6) 26.7 (4.5) <0.001 7,188 
Hyperlipidemia / 
hypercholesterolemia (%) 
48.7 45.5 0.004 8,405 
Hypertension (%) 31.0 35.8 <0.001 8,301 
History of hypertension (%) 55.2 44.4 <0.001 5,348 
Medication use     
Hypolipidemics (%) 42.7 44.7 0.230 4,004 
Beta-blockers (%) 68.7 74.0 <0.001 8,833 
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Aspirin (%) 86.3 87.8 0.051 7,561 
Calcium-channel blockers / 
antagonists (%) 
19.3 14.9 <0.001 7,056 
ACE-inhibitors (%) 48.1 49.6 0.160 8,550 
Antidepressant use (%) 10.1 3.2 <0.001 5,507 
ACE: angiotensin converting-enzyme; BMI: body mass index; CABG: coronary artery bypass graft; HF: heart failure;  
LVEF: left ventricular ejection fraction; MI: myocardial infarction; PTCA: percutaneous transluminal coronary  
angioplasty; SD: standard deviation
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Figure 2: survival curves all-cause mortality and cardiovascular events adjusted for age and sex 
 
Left panel: all-cause mortality survival curves based on 10 studies and 7691 patients. Right panel: cardiovascular events survival curves based on 7 studies and 6616 patients. 
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Figure 3: Survival curves all-cause mortality and cardiovascular events for the base and fully adjusted models 
 
 
Top panel: All-cause mortality survival curves based on 3 studies and 2239 patients. Bottom panel: Cardiovascular events survival curves based on 2 studies and 1973 patients. 
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Table 3: Hazard ratios for all-cause mortality, unadjusted and adjusted for cardiac 
disease severity and other health-related variables 
 
HR unadjusted1  
(95% CI) 
HR adjusted1 
(95% CI) 
% change N / n 
studies2 
Sociodemographic 
variables 
    
Age, sex3 1.26 (1.18-1.35)*** 1.32 (1.26-1.38)*** +17% 7,628 / 10 
Cardiac disease 
severity variables 
    
History of MI 1.32 (1.26-1.39)*** 1.29 (1.24-1.36)*** -8% 7,543 / 10 
LVEF (low vs normal) 1.30 (1.23-1.39)*** 1.25 (1.18-1.33)*** -15% 3,115 / 5 
Killip class (I vs II, III 
or IV) 
1.31 (1.25-1.38)*** 1.25 (1.18-1.32)*** -19% 5,924 / 6 
General health 
variables 
    
Diabetes 1.31 (1.25-1.38)*** 1.29 (1.22-1.36)*** -7% 7,587 / 10 
Smoking 1.33 (1.27-1.39)*** 1.33 (1.27-1.39)*** -1% 7,485 / 10 
BMI 1.34 (1.27-1.41)*** 1.34 (1.28-1.41)*** 0% 6,133 / 7 
Model including all 
variables 
    
(Age, sex) history of 
MI, LVEF, Killip class, 
diabetes, smoking, BMI 
1.33 (1.23-1.44)*** 1.23 (1.15-1.31)*** -28% 2,226 / 3 
(Age, sex) history of 
MI, LVEF, Killip class 
1.32 (1.24-1.40)*** 1.22 (1.13-1.31)*** -29% 2,400 / 3  
ACM: all-cause mortality; BMI: body mass index; CI: confidence interval; HR: hazard ratio; LVEF: left ventricular 
ejection fraction; MI: myocardial infarction 
Note that column 2 represents unadjusted HRs, based on analyses including only those patients that had scores 
available for the variables concerned  
1
 depression is included in all the models as a continuous variable (z-score) 
2
 depending on availability of these variables in each study 
3
 the model including depression, age, and sex is the comparison model 
*** p<0.001 
** p<0.01 
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Table 4: Hazard ratios for cardiovascular events, unadjusted and adjusted for 
cardiac disease severity and other health-related variables 
 
HR unadjusted1  
(95% CI) 
HR adjusted1 
(95% CI) 
% change N / n studies2 
Sociodemographic 
variables 
    
Age, sex3 1.18 (1.13-1.23)*** 1.19 (1.14-1.24)*** +2% 6,556 / 7 
Cardiac disease severity 
variables 
    
History of MI 1.19 (1.13-1.24)*** 1.17 (1.12-1.22)*** -9% 6,475 / 7 
LVEF (low vs normal) 1.18 (1.12-1.25)*** 1.16 (1.10-1.23)*** -10% 2,904 / 5 
Killip class (I vs II, III or 
IV) 
1.17 (1.12-1.22)*** 1.15 (1.11-1.20)*** -12% 5,410 / 5 
General health variables     
Diabetes 1.19 (1.14-1.24)*** 1.17 (1.13-1.22)*** -7% 6,522 / 7 
Smoking 1.19 (1.13-1.24)*** 1.19 (1.13-1.24)*** 0% 6,416 / 7 
BMI 1.18 (1.12-1.25)*** 1.18 (1.12-1.25)*** 0% 5,757 / 5 
Model including all 
variables 
    
(Age, sex) history of MI, 
LVEF, Killip class, 
diabetes, smoking, BMI 
1.17 (1.05-1.30)** 1.12 (1.01-1.25)* -25% 1,962 / 2 
(Age, sex) history of MI, 
LVEF, Killip class 
1.17 (1.09-1.26)*** 1.13 (1.07-1.19)*** -21% 2,178 / 3 
BMI: body mass index; CI: confidence interval; CVE: cardiovascular events; HR: hazard ratio; LVEF: left ventricular 
ejection fraction; MI: myocardial infarction 
Note that column 2 represents unadjusted HRs, based on analyses including only those patients that had scores 
available for the variables concerned  
1
 depression is included in all the models as a continuous variable (z-score) 
2
 depending on availability of these variables in each study 
3
 the model including depression, age, and sex is the comparison model 
*** p<0.001 
** p<0.01 
* p<0.05 
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Table 5: Odds ratios for all-cause mortality, unadjusted and adjusted for cardiac 
disease severity and health related variables 
All-cause mortality OR unadjusted1  
(95% CI) 
OR adjusted1 
(95% CI) 
% 
change 
N / n 
studies2 
Sociodemographic 
variables 
    
Age, sex*** 1.33 (1.25-1.41)*** 1.41 (1.34-1.49)*** +18% 8.362 / 12 
General health variables     
Diabetes 1.41 (1.33-1.48)*** 1.37 (1.30-1.45)*** -7% 8273 / 12 
Smoking 1.42 (1.35-1.49)*** 1.42 (1.34-1.49)*** -1% 8192 / 12 
BMI 1.43 (1.35-1.52)*** 1.40 (1.35-1.52)*** 0% 6132 / 7 
Cardiac disease severity 
variables 
    
History of MI 1.41 (1.33-1.487)*** 1.37 (1.30-1.44)*** -8% 8007 / 11 
LVEF 1.36 (1.25-1.49)*** 1.31 (1.21-1.43)*** -12% 3330 / 6 
Killip class 1.40 (1.33-1.48)*** 1.35 (1.26-1.44)*** -13% 6367 / 7 
Model Including all 
variables 
    
(Age, sex) history of MI, 
LVEF, Killip class, diabetes, 
smoking, BMI 
1.37 (1.18-1.59)*** 1.24 (1.07-1.44)*** -30% 2225 / 3 
 
(Age, sex) history of MI, 
LVEF, Killip class 
1.36 (1.24-1.50)*** 1.27 (1.17-1.37)*** -25% 
 
2399 / 3 
ACM: all-cause mortality; BMI: body mass index; CI: confidence interval; HR: hazard ratio; LVEF: left ventricular 
ejection fraction; MI: myocardial infarction 
1
 depression is included in all the models as a continuous variable (z-score) 
2
 depending on availability of these variables in each study 
3
 the model including depression, age, and sex is the comparison model 
*** p<0.001 
** p<0.01 
* p<0.05 
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Table 6: Odds ratios for cardiovascular events, unadjusted and adjusted for cardiac 
disease severity and health related variables 
 
OR unadjusted1  
(95% CI) 
OR adjusted1 
(95% CI) 
% change N / n studies2 
Sociodemographic variables     
Age, sex 1.25 (1.19-1.31)*** 1.25 (1.19-1.32)*** +1% 8,878 / 11 
General health variables     
Diabetes 1.25 (1.19-1.32)*** 1.24 (1.18-1.29)*** -6% 8,770 / 11 
Smoking 1.25 (1.20-1.31)*** 1.26 (1.20-1.32)*** 0% 8,654 / 11 
BMI 1.25 (1.16-1.35)*** 1.25 (1.16-1.35)*** 0% 6,759 / 6 
Cardiac disease severity 
variables 
    
History of MI 1.24 (1.17-1.32)*** 1.23 (1.16-1.29)*** -7% 8,415 / 10 
LVEF 1.26 (1.18-1.35)*** 1.24 (1.15-1.34)*** -8% 3,123 / 6 
Killip class 1.24 (1.16-1.32)*** 1.22 (1.16-1.28)*** -7% 6,874 / 7 
Model Including all variables     
(Age, sex) history of MI, 
LVEF, Killip class, diabetes, 
smoking, BMI 
1.24 (1.07-1.44)** 1.18 (1.00-
1.40,)p=0.053 
-23% 1,964 / 2 
(Age, sex) history of MI, 
LVEF, Killip class 
1.23 (1.17-1.30)*** 1.19 (1.12-1.26)*** -19% 2,181 / 3 
BMI: body mass index; CI: confidence interval; CVE: cardiovascular events; HR: hazard ratio; LVEF: left ventricular 
ejection fraction; MI: myocardial infarction 
1
 depression is included in all the models as a continuous variable (z-score) 
2
 depending on availability of these variables in each study 
3
 the model including depression, age, and sex is the comparison model 
*** p<0.001 
** p<0.01 
* p<0.05 
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Appendix 1: Search strings PubMed, Embase, and PsycINFO 
 
PubMed 
(“mood disorders” [MeSH] OR depression [MeSH] OR depression [tiab] OR depressive 
[tiab]) AND (“myocardial infarction” [MeSH] OR “myocardial infarction” [tiab]) 
humans only 
 
Embase 
(“mood disorder” OR “depressive symptoms” OR “depressive symptomatology” OR 
depressed) AND (“heart infarction” OR “myocardial infarction”) 
map to preferred terminology, explosion search, search terms must me major focus, 
search humans only, Embase only. 
 
PsycInfo 
((major depression) OR depression OR depressive) AND ((myocardial infarctions) OR 
(myocardial infarction))
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Appendix 2: Overview of non-participating studies 
First author; 
study name; 
country 
Start 
of 
study 
N / % 
male 
Inclusion criteria Exclusion criteria Mean 
age 
Depression 
measurement 
instrument / cut-
off score 
N / % 
depressed 
Follow-
up time 
(days) 
Reason for 
exclusion 
D.K. Ahern(85) 
 
CAPS 
 
USA 
1983 351 / na MI 6-60 days pre-enrollm., 
basel. Holter mon. ≥ 10 
ventr. prem. compl./hour or 
≥ 5 ep. of unsust. ventr. 
tach.; age < 75; LVEF > 
20% 
illiterate in English; 
inadequate eyesight; poor 
dominant hand mobility 
nr BDI, version nr; 
cutoff nr 
140 / 40%  365 unable to contact 
N. Frasure-
Smith(16) 
 
EPPI / M-HART 
 
Canada 
1991 896 / 
68% 
standardized criteria for MI other life-threat. med. illn.; 
cogn. impairm.; periproc. 
MI; unable to commun.; too 
ill;  lived too far away; adm. 
reas. 
59 BDI, version nr / ≥ 
10 
290 / 32% 365 not interested 
N. Frasure-
Smith(86) 
 
Canada 
1991 222 / 
78% 
standardized criteria for MI other life-threat. med. illn.; 
cogn. impairm.; periproc. 
MI; unable to commun.; too 
ill 
60 BDI, version nr / ≥ 
10 
 
DIS 
66 / 31% 
 
34 / 15% 
549 not interested 
J. Irvine(87) 
 
CAMIAT  
 
Canada 
1990 301 / 
82% 
standardized criteria for MI; 
freq. or repet. ventr. depol. 
within 6 to 45 days of MI 
illiterate in English and 
French; death before 2-week 
postrandomiz. clinic visit 
64 BDI, version nr / ≥ 
10 
98 / 33% 732 unable to contact 
M.W. 
Kaufmann(88) 
 
USA 
1995 331 / 
66% 
standardized criteria for MI other life-threat. med. illn.; 
cogn. impairm.; illiterate in 
English; too ill; in hosp. 
mortality 
65 DIS / ≥ 5 87 / 26% 365 unable to contact 
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K.H. Ladwig(89) 
 
PILP 
 
Germany 
1983 553 / 
100% 
standardized criteria for MI; 
male sex; age < 66 
nr 54 KSb-S / 90% 80 / 14% 183 data not 
available 
R.A. Mayou(90) 
 
OMIS 
 
UK 
1994 344 / 
73% 
standardized criteria for MI age > 80; index MI within 28 
days of preceding event  
63 HADS / ≥ 11 26 / 8% 549 data not 
available 
D. Nakatani(91) 
 
OACIS 
 
Japan 
1999 1803 / 
na 
standardized criteria for MI unable to commun.; in-hosp. 
mortality; major psych. 
disorder 
na ZSDS / ≥ 40 860 / 48% 732 data not 
available 
J.S. 
Rumsfeld(92) 
 
EPHESUS 
 
USA 
1999 634 / 
72% 
standardized criteria for MI; 
MI complic. by LV 
dysfunction and heart failure 
valvular or congen. heart 
failure; diuretics other than 
eplerenone 
65 MOS-D / ≥ 0.06 143 / 23% 488 unable to contact 
P. 
Silverstone(93) 
 
UK 
1984 108 / 
75% 
MI nr 63 MADRS / ≥ 14 48 / 44% 8 unable to contact 
K.G. 
Smolderen(94) 
PREMIER 
 
USA 
2003 2347 / 
68% 
standardized criteria for MI; 
age ≥ 18 
transfer from other fac. > 24 
hours after MI; incarcerated; 
unable to commun. 
61 PHQ / ≥ 10 516 / 22% 1460 data not 
available 
C. Sørensen(95) 
 
Denmark 
1999 761 / 
76% 
standardized criteria for MI other life-threat. med. illn.; 
age > 76; major psych. 
disorder; unable to speak 
Danish; not living in 
Denmark 
59 MDI / cutoff nr 73 / 10% 365 unable to contact 
J.J. Strik(96) 
 
The Netherlands 
1997 206 / 
76% 
standardized criteria for MI; 
first MI 
other life-threat. med. illn.; 
major psych. disorder; 
unable to commun.; living 
too far away 
59 SCID 63 / 31% 1095 unable to contact 
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S.J. Sydeman(97) 
 
USA 
1996 111 / 
60% 
standardized criteria for MI other life-threat. med. illn.; 
periproc. MI; age < 35; 
illiterate in English; cogn. 
impairm.; too ill; in-hosp. 
mortality 
62 BDI / ≥ 10 
 
SCID 
BDI: nr 
 
SCID: 5 / 
5% 
183 data not 
available 
BDI: Beck Depression Inventory; CAMIAT: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial; CAPS: Cardiac Arrhythmia Pilot Study; DIS: Diagnostic Interview 
Schedule; EPHESUS: Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study; EPPI: Emotions and Prognosis Post-Infarct; KSb-S: Klinische 
Selbstbeurteilungsskalen aus dem Münchner psychiatrische Informations-System; MADRS: Montgomery-Åsberg Depression Rating Scale; MDI: Major Depression Inventory; M-
HART: Montréal Heart Attack Readjustment Trial; MOS-D: Medical Outcomes Study-Depression Score; nr: not reported; OACIS: Osaka Acute Coronary Insufficiency Study; 
OMIS: Oxford Myocardial Incidence Study; PHQ: Patient Health Questionnaire; PILP: Post Infarction Late Potential Study; PREMIER: Prospective Registry Evaluating outcomes 
after Myocardial Infarction: Events and Recovery; SCID: Structured Clinical Interview for DSM; ZSDS: Zung Self-rating Depression Scale  
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Appendix 3: MOOSE checklist 
Item Page 
Reporting of background should include  
Problem definition 4 
Hypothesis statement not applicable 
Description of study outcome(s) 9 
Type of exposure or intervention used 7 
Type of study designs used 6 
Study population 6 
Reporting of search strategy should include  
Qualifications of searchers (eg, librarians and investigators) 51 
Search strategy, including time period included in the synthesis and 
keywords 
5,6, appendix 1 
Effort to include all available studies, including contact with 
authors 
6, 7 
Databases and registries searched 5 
Search software used, name and version, including special features 
used (eg, explosion) 
Appendix 1 
Use of hand searching (eg, reference lists of obtained articles) 5, 6 
List of citations located and those excluded, including justification Figure 1 
Method of addressing articles published in languages other than 
English 
5 
Method of handling abstracts and unpublished studies not applicable 
Description of any contact with authors 6, 7 
Reporting of methods should include  
Description of relevance or appropriateness of studies assembled 
for assessing the hypothesis to be tested 
6 
Rationale for the selection and coding of data (eg, sound clinical 
principles or convenience) 
7-9 
Documentation of how data were classified and coded (eg, multiple 
raters, blinding, and interrater reliability) 
not available 
Assessment of confounding (eg, comparability of cases and controls 
in studies where appropriate) 
not available 
Assessment of study quality, including blinding of quality 
assessors; stratification or regression on possible predictors of study 
results 
reported 
elsewhere5 
Assessment of heterogeneity 10 
Description of statistical methods (eg, complete description of fixed 
or random effects models, 
9-13 
justification of whether the chosen models account for predictors of 
study results, 
9-13 
dose-response models, or cumulative meta-analysis) in sufficient 
detail to be replicated 
not applicable 
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Provision of appropriate tables and graphics 32-34 
Reporting of results should include  
Graphic summarizing individual study estimates and overall 
estimate 
Not applicable 
Table giving descriptive information for each study included 33-35 
Results of sensitivity testing (eg, subgroup analysis) Not applicable 
Indication of statistical uncertainty of findings 25-28 
Reporting of discussion should include  
Quantitative assessment of bias (eg, publication bias) 20 
Justification for exclusion (eg, exclusion of non–English-language 
citations) 
Appendix 2 
Assessment of quality of included studies Reported 
elsewhere5 
Reporting of conclusions should include  
Consideration of alternative explanations for observed results 21, 22, 27, 28 
Generalization of the conclusions (ie, appropriate for the data 
presented and within the domain of the literature review) 
25 
Guidelines for future research 28, 29 
Disclosure of funding source 30-31 
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